Curaleaf Holdings (CURLF) Capital Expenditures Growth (3y) (2022 - 2024)

Curaleaf Holdings (CURLF) Capital Expenditures Growth (3y) (2022 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex Growth (3y) (Qtr)
1	Haleon	43.96 Bn	43.00 Bn	-	-
2	Teva Pharmaceutical Industries	43.23 Bn	39.58 Bn	2.15 Bn	-4.39%
3	Zoetis	31.76 Bn	30.08 Bn	1.05 Bn	-11.01%
4	Takeda Pharmaceutical	28.68 Bn	22.88 Bn	5.10 Bn	-0.22%
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn	34.19%
6	Viatris	18.69 Bn	17.81 Bn	1.46 Bn	-8.00%
7	Neurocrine Biosciences	15.56 Bn	15.17 Bn	935.80 Mn	4.68%
8	Elanco Animal Health	11.78 Bn	11.25 Bn	798.00 Mn	-7.72%
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-	-
10	Curaleaf Holdings	2.48 Bn	2.38 Bn	169.91 Mn	-

Download Data